A Novel Sensing Platform for the Determination of Alkaline Phosphatase Based on SERS-fluorescent Dual-Mode Signals.

Wei Wang,Yue Zhang,Wei Zhang,Yibing Liu,Pinyi Ma,Xinghua Wang,Ying Sun,Daqian Song

DOI: https://doi.org/10.1016/j.aca.2021.338989

IF: 6.911

2021-01-01

Analytica Chimica Acta

Abstract:Alkaline phosphatase (ALP), as an important biomarker, is closely associated with various diseases. Multi-mode sensing platforms can combine the advantages of different technologies and solve their inherent or practical limitations. Herein, we developed a sensing platform for the determination of alkaline phos-phatase (ALP) in human serum based on SERS-fluorescent dual-mode assay. Based on the fact that ALP can trigger the in-situ reaction between o-phenylenediamine (OPD) and ascorbic acid (AA), we con-nected gold nanoparticles (AuNPs) to 3,4-diaminobenzene-thiol (OPD(SH)) through an AueS covalent bond to synthesize a nanoprobe (OPD(S)-AuNPs). The nanoprobe provides a unique interactive ammo-nium group for the diol group of AA, which was then used to generate an N-heterocyclic compound that can exhibit good SERS and fluorescence signals without adding SERS reporter and fluorophores or quantum dots (QDs). When being excited at different wavelengths as 360 nm and 785 nm, the fluo-rescence and SERS signals can be separately generated, which can avoid the disturbance from each other. The response of the fluorescence system was linear from 1.0 to 20 mU mL(-1) (R-2 = 0.994) with a detection limit of 0.3 mU mL(-1), while that of the SERS system was linear from 0.5 to 10 mU mL(-1) (R-2 = 0.998) with a detection limit of 0.2 mU mL(-1). The sensing platform developed was further employed in ALP inhibitor evaluation. (C) 2021 Elsevier B.V. All rights reserved.